Coagulation Factor VIIa, Human, recombinant

ATC (Anatomical Therapeutic Chemical Classification)

B02BD05

Therapeutic Categories

Hemostatic agent

Blood coagulation factor substitute

Foreign Names

• Factor VIIa coagulationis humanus (ADNr) (Latin)
• Blutgerinnungsfaktor VIIa vom Menschen, rekombinant (German)
• Facteur VIIa de coagulation humain, recombinant (French)

Generic Names

• rFVlla (IS)
• Eptacog Alfa (Activated) (OS: BAN)

Brand Names

• NiaStase
  Novo Nordisk, Canada



• NovoSeven
  Novo Nordisk, Austria; Novo Nordisk, Australia; Novo Nordisk, Bosnia & Herzegowina; Novo Nordisk, Belgium; Novo Nordisk, Bahrain; Novo Nordisk, Switzerland; Novo Nordisk, China; Novo Nordisk, Cyprus; Novo Nordisk, Czech Republic; Novo Nordisk, Germany; Novo Nordisk, Denmark; Novo Nordisk, Finland; Novo Nordisk, France; Novo Nordisk, United Kingdom; Novo Nordisk, Greece; Novo Nordisk, Hong Kong; Novo Nordisk, Croatia (Hrvatska); Novo Nordisk, Hungary; Novo Nordisk, Ireland; Novo Nordisk, Israel; Novo Nordisk, Israel; Novo Nordisk, Italy; Novo Nordisk, Jordan; Novo Nordisk, Japan; Novo Nordisk, Kuwait; Novo Nordisk, Luxembourg; Novo Nordisk, Mexico; Novo Nordisk, Malaysia; Novo Nordisk, Netherlands; Novo Nordisk, Norway; Novo Nordisk, New Zealand; Novo Nordisk, Poland; Novo Nordisk, Romania; Novo Nordisk, Serbia; Novo Nordisk, Russian Federation; Novo Nordisk, Sweden; Novo Nordisk, Singapore; Novo Nordisk, Slovenia; Novo Nordisk, Slovakia; Novo Nordisk, Tunisia; Novo Nordisk, Turkey; Novo Nordisk, Taiwan; Novo Nordisk, United States; Novo Nordisk, South Africa

International Drug Name Search

Glossary

BAN	British Approved Name
IS	Inofficial Synonym
OS	Official Synonym

Click for further information on drug naming conventions and International Nonproprietary Names.